Why is Jagsonpal Pharma falling/rising?

As of 04-Aug, Jagsonpal Pharmaceuticals Ltd is experiencing a price increase, with its current price at Rs 273.40, reflecting a rise of Rs 2.05 or 0.76%. Despite a recent intraday low of Rs 261.05, the stock has shown strong performance over the past month, with an increase of 18.18%. However, it has faced a decline of 6.55% over the past week. The company has demonstrated solid fundamentals, including a low debt-to-equity ratio and significant growth in operating profit at an annual rate of 42.31%. Additionally, it has reported positive results for the last five consecutive quarters, with a notable increase in net sales and a high debtors turnover ratio, contributing to its overall positive sentiment in the market.
In the broader market context, the stock's recent performance has outpaced the benchmark Sensex, which has only gained 0.16% over the past week. While Jagsonpal Pharmaceuticals has shown a robust long-term performance, generating a 76.61% return over the past year, the recent drop in investor participation, with a 68% decrease in delivery volume, raises concerns about liquidity. Nonetheless, the stock remains liquid enough for trading, indicating that while there may be short-term fluctuations, the long-term outlook remains favorable due to its strong financial metrics and market-beating performance.